- Home
- STTK vs ISTR Comparison
STTK vs ISTR Comparison
Compare STTK & ISTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- ISTR
- Stock Information
- Founded
- STTK 2016
- ISTR 2006
- Country
- STTK United States
- ISTR United States
- Employees
- STTK N/A
- ISTR N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- ISTR Major Banks
- Sector
- STTK Health Care
- ISTR Finance
- Exchange
- STTK Nasdaq
- ISTR Nasdaq
- Market Cap
- STTK 173.6M
- ISTR 166.7M
- IPO Year
- STTK 2020
- ISTR 2014
- Fundamental
- Price
- STTK $3.65
- ISTR $18.70
- Analyst Decision
- STTK Strong Buy
- ISTR Buy
- Analyst Count
- STTK 3
- ISTR 1
- Target Price
- STTK $10.67
- ISTR $13.50
- AVG Volume (30 Days)
- STTK 122.9K
- ISTR 34.5K
- Earning Date
- STTK 11-07-2024
- ISTR 10-17-2024
- Dividend Yield
- STTK N/A
- ISTR 2.16%
- EPS Growth
- STTK N/A
- ISTR N/A
- EPS
- STTK N/A
- ISTR 1.53
- Revenue
- STTK $4,123,999.00
- ISTR $80,646,000.00
- Revenue This Year
- STTK $164.45
- ISTR N/A
- Revenue Next Year
- STTK N/A
- ISTR $13.81
- P/E Ratio
- STTK N/A
- ISTR $12.14
- Revenue Growth
- STTK 380.09
- ISTR N/A
- 52 Week Low
- STTK $1.33
- ISTR $9.07
- 52 Week High
- STTK $11.76
- ISTR $19.00
- Technical
- Relative Strength Index (RSI)
- STTK 50.03
- ISTR 62.46
- Support Level
- STTK $3.63
- ISTR $17.39
- Resistance Level
- STTK $3.94
- ISTR $19.00
- Average True Range (ATR)
- STTK 0.23
- ISTR 0.39
- MACD
- STTK 0.04
- ISTR 0.01
- Stochastic Oscillator
- STTK 49.12
- ISTR 81.37
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About ISTR Investar Holding Corporation
Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.